Table 4.
Prepandemic 1 June 2018–30 November 2019 | Pandemic 1 June 2020–30 November 2021 | Difference (%) | p Value | |
---|---|---|---|---|
Suprainguinal revascularization | ||||
Ilio-femoral by-pass | 52 (32.91%) | 32 (36.36%) | 3.45 | 0.60 |
Aorto-femoral by-pass | 50 (31.65%) | 32 (36.36%) | 4.72 | 0.45 |
Aorto-bifemoral by-pass | 56 (35.44%) | 24 (27.27%) | −8.17 | 0.19 |
Age mean ± SD (min–max) | 67.14 ± 8.54 (45–87) | 65.59 ± 7.7 (47–82) | — | 0.14a |
Sex (M/F) | 79.74%/20.26% | 81.81%/18.19% | — | 0.82b |
Duration of hospital stay (days), median [interquartile range] | 11.5 [8–14] | 9 [7–11.5] | — | <0.0001c |
Infrainguinal revascularization | ||||
FP bypass with saphenous vein | 28 (8.78%) | 19 (15.07%) | 6.30 | 0.054 |
FP bypass with grafts | 230 (72.10%) | 90 (71.43%) | −0.67 | −0.88 |
Remote endarterectomy | 61 (19.12%) | 17 (13.49%) | −5.63 | 0.16 |
Age mean ± SD (min–max) | 68.77 ± 8.95 (30–93) | 68.13 ± 8.63 (36–91) | — | 0.48a |
Sex (M/F) | 81.81%/18.19% | 85.71%/14.29% | — | 0.37b |
Duration of hospital stay (days), median [interquartile range] | 10 [7–14] | 7 [6–10] | — | <0.0001c |
Amputation | ||||
AKA | 33 (53.23%) | 47 (52.23%) | −1 | 0.90 |
BKA | 29 (46.77%) | 43 (47.77%) | 1 | |
Age mean ± SD (min–max) | 68.19 ± 9.05 (36–91) | 70.71 ± 9.75 (47–91) | — | 0.1a |
Sex (M/F) | 77.41%/22.59% | 76.66%/23.34% | — | 0.92b |
Duration of hospital stay (days), median [interquartile range] | 8.5 [6–11] | 11.5 [7–11] | — | 0.001c |
Endovascular treatment | ||||
Balloon angioplasty | 74 (64.91%) | 21 (55.26%) | −9.65 | 0.28 |
Stenting | 40 (35.09%) | 17 (44.74%) | 9.65 | |
Age mean ± SD (min–max) | 66.42 ± 11.25 (32–88) | 60.55 ± 15.46 (19–84) | — | 0.03a |
Sex (M/F) | 77.19%/22.81% | 63.15%/36.86% | — | 0.13b |
Duration of hospital stay (days), median [interquartile range] | 9 [5–13] | 5.5 [4–8] | — | <0.0001c |
FP, femoral-popliteal; SD, standard deviation; AKA, above-knee amputation; BKA, below-knee amputation.
Student’s t-test.
Chi-square test.
Mann–Whitney test.